Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | EDNRA | P25101 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | EDNRB | P24530 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31515627 | 0.79 | KMT2A (0.49) | KMT2AMEN1ESR1ESR2GAA | |
| SCHEMBL9803 | 0.79 | KMT2A (0.49) | KMT2AMEN1ESR1ESR2GAA | |
| SCHEMBL10793441 | 0.78 | HSD11B1 (0.42) | GAAEDNRACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL8661206 | 0.77 | ALDH1A1 (0.49) | KMT2AGAAPOLBALDH1A1KDM4E | |
| SCHEMBL260819 | 0.77 | MEN1 (0.47) | KMT2AMEN1ESR1ESR2GAA | |
| SCHEMBL8019502 | 0.77 | KMT2A (0.47) | KMT2AMEN1ESR1ESR2GAA | |
| SCHEMBL31244372 | 0.77 | MEN1 (0.47) | KMT2AMEN1ESR1ESR2GAA | |
| SCHEMBL2187087 | 0.76 | CA1 (0.52) | KMT2AMEN1EDNRAHTR6EDNRB | |
| SCHEMBL3396632 | 0.75 | KMT2A (0.46) | KMT2AMEN1ESR1ESR2GAA | |
| SCHEMBL8984873 | 0.75 | KMT2A (0.51) | KMT2AMEN1ESR1ESR2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129550-A1 | POLYORGANOSILOXANE COMPOSITION | DOW SILICONES CORPORATION (US) | 2025-06-26 | — | — | WO | claimed |
| US-20110220844-A1 | SULFONATE MODIFIED NANOCRYSTALS | Life Technologies Corporation | 2011-09-15 | — | — | US | claimed |
| EP-2342161-A2 | SULFONATE MODIFIED NANOCRYSTALS | Life Technologies Corporation (US) | 2011-07-13 | — | — | EP | claimed |
| WO-2010040111-A2 | SULFONATE MODIFIED NANOCRYSTALS | Life Technologies Corporation (US) | 2010-04-08 | — | — | WO | claimed |
| WO-2025129550-A1 | POLYORGANOSILOXANE COMPOSITION | DOW SILICONES CORPORATION (US) | 2025-06-26 | — | — | WO | disclosed |
| US-20250066621-A1 | COMPOSITION FOR FILM FORMATION AND METHOD FOR MANUFACTURING SUBSTRATE | CENTRAL GLASS COMPANY, LIMITED (JP) | 2025-02-27 | — | — | US | disclosed |
| CN-119278504-A | Substrate processing method and substrate manufacturing method | 中央硝子株式会社 | 2025-01-07 | — | — | CN | disclosed |
| US-12163188-B2 | Polymerase compositions and methods | Life Technologies Corporation (US) | 2024-12-10 | — | — | US | disclosed |
| WO-2024248021-A1 | FILM-FORMING COMPOSITION, METHOD FOR PRODUCING SUBSTRATE, AND METHOD FOR PRODUCING FILM-FORMING COMPOSITION | セントラル硝子株式会社 | 2024-12-05 | — | — | WO | disclosed |
| EP-4459666-A1 | COMPOSITION FOR FILM FORMATION AND METHOD FOR PRODUCING SUBSTRATE | Central Glass Company, Limited (JP) | 2024-11-06 | — | — | EP | disclosed |
| WO-2024143097-A1 | SUBSTRATE TREATING METHOD AND SUBSTRATE MANUFACTURING METHOD | セントラル硝子株式会社 | 2024-07-04 | — | — | WO | disclosed |
| US-20230055565-A1 | POLYMERASE COMPOSITIONS & METHODS | Life Technologies Corporation (US) | 2023-02-23 | — | — | US | disclosed |
| WO-2010111691-A2 | CONJUGATES OF BIOMOLECULES TO NANOPARTICLES | LIFE TECHNOLOGIES CORP (US) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010111690-A2 | POLYMERASE COMPOSITIONS AND METHODS | Life Technologies Corporation (US) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010111674-A2 | METHODS AND APPARATUS FOR SINGLE MOLECULE SEQUENCING USING ENERGY TRANSFER DETECTION | Life Technologies Corporation (US) | 2010-09-30 | — | — | WO | disclosed |
| US-20100217020-A1 | PROCESS FOR PRODUCING VITAMIN D DERIVATIVE USING CONVERGENT METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-08-26 | — | — | US | disclosed |
| WO-2010040111-A2 | SULFONATE MODIFIED NANOCRYSTALS | Life Technologies Corporation (US) | 2010-04-08 | — | — | WO | disclosed |
| US-20090253905-A1 | PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH ALKYL- OR ARYLSULFONATE ANIONS OR ALKYL- OR ARYLCARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT | MERCK PATENT GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
| EP-1955999-A1 | METHOD FOR PRODUCING VITAMIN D DERIVATIVE BY USING CONVERGENT METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-4565883-A | Cyanoacrylate adhesive composition | TEROSON GMBH (DE) | 1986-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100217020-A1 | PROCESS FOR PRODUCING VITAMIN D DERIVATIVE USING CONVERGENT METHOD | CYP2R1, CYP24A1, VDR | KMT2A 2928/4885MEN1 2805/4885ESR1 3553/4885 |
| US-20090253905-A1 | PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH ALKYL- OR ARYLSULFONATE ANIONS OR ALKYL- OR ARYLCARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT | ARSA, STS, SCLY | KMT2A 2870/4885MEN1 4228/4885ESR1 2694/4885 |
| US-12163188-B2 | Polymerase compositions and methods | POLN, POLI, POLRMT | KMT2A 2735/4885MEN1 4479/4885ESR1 3418/4885 |
| US-20230055565-A1 | POLYMERASE COMPOSITIONS & METHODS | POLN, POLI, POLRMT | KMT2A 2450/4885MEN1 4477/4885ESR1 3612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.